Partner, Patent Attorney
Life Sciences


Christopher (Chris) handles the full range of patent work in the life sciences sector, from pre-drafting advice to drafting and prosecution of worldwide patent portfolios. He also has experience with IP due diligence and European oppositions.

Areas of Expertise

  • Biological therapeutics, including antibody-drug conjugates
  • Prognostic and treatment response predictive methods, including related computational biology
  • Cancer therapeutics, diagnostics and biomarkers
  • Nanomedicine


Chris works with a wide range of clients in the life sciences field, including universities, charities and research institutions, spin-outs and SMEs to multinationals.


Chris has a degree in natural sciences (pharmacology) from the University of Cambridge and a PhD from University College London, relating to the neurochemistry of Alzheimer’s disease. He carried out post-doctoral research at a multinational pharmaceutical company before joining Mewburn Ellis LLP in 2004, qualifying as a Chartered Patent Attorney in 2007 and a European Patent Attorney in 2008. He joined the partnership in 2011.